Stock vs Stock Comparison

IQVIA Holdings Inc. vs AbbVie Inc.

ABBV wins the Tale of the Tape 5–4.

IQV$206.26
ABBV$254.49

🏆 Tale of the Tape

45
IQVABBV
8.3%Profitability (Net Margin)6.9%
26.2xValuation (P/E)124.8x
8.5%Efficiency (ROIC)8.3%
4/9Health (Piotroski F)7/9
1.9Safety (Altman Z)2.4
5.9%Growth (Rev YoY)8.6%
0.71Risk (Sharpe 1Y)1.11
3.52xBalance Sheet (D/E)-42.50x
4.43%FCF Yield3.54%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.180
252-Day Correlation
0.094
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricIQVABBV
Market Cap$34.4B$449.6B
P/E Ratio26.2x124.8x
Forward P/E14.6x15.6x
P/B5.53x-67.56x
Dividend Yield2.72%
Beta1.200.28

Quantitative Metrics

MetricIQVABBV
DCF Fair Value$119.76$123.27
DCF Upside-41.9%-51.6%
Piotroski F4/97/9
Altman Z1.952.37
Beneish M-2.59-2.87
FCF Yield4.43%3.54%
Net Debt/EBITDA3.4x3.0x
ROIC8.5%8.3%
WACC9.8%7.5%
ROIC – WACC-1.4pp0.7pp
Gross Margin33.3%70.2%
Net Margin8.3%6.9%
Rev Growth YoY5.9%8.6%
Sharpe (1Y)0.711.11
Max Drawdown 3Y
FCF Payout Ratio65%

IQV Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

IQV found in:

XLV0.60%
VOE0.56%
VHT0.48%
VO0.31%
RSP0.18%
ONEO0.14%
VTV0.12%
SPYV0.12%
SCHG0.12%
IWD0.09%
VONV0.09%
SPLG0.06%
ESGV0.06%
IVV0.06%
SPY0.05%
SPTM0.05%
VONE0.05%
ITOT0.05%
VOO0.05%
SCHX0.05%
SCHB0.05%
VTI0.04%
URTH0.04%
QUS0.03%
ACWI0.03%

ABBV found in:

XLV7.69%
IYH7.48%
VHT6.56%
HDV5.44%
SCHD3.53%
DGRO3.05%
MGV2.10%
VIG1.94%
DGRW1.93%
VYM1.85%
JEPI1.73%
VTV1.66%
SDY1.61%
NOBL1.49%
IWF1.39%
SCHV1.38%
VONV1.15%
XBI1.11%
SPYV0.82%
ESGV0.78%
IVV0.72%
SPY0.69%
VOO0.69%
SPLG0.68%
SCHX0.66%
SPTM0.64%
VONE0.64%
ITOT0.63%
SCHB0.62%
VTI0.61%
SPYG0.59%
URTH0.48%
VFVA0.41%
VT0.38%
QUS0.38%
ACWI0.38%
VFMV0.25%
RSP0.18%
VONG0.11%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

IQV vs ABBV: Head-to-Head Analysis

IQVIA Holdings Inc. (IQV) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABBV leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, IQV generates a return on invested capital (ROIC) of 8.5% compared to ABBV's 8.3%. This suggests IQV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between IQV and ABBV is 0.180, indicating low correlation, making them an effective diversification pair in a portfolio context.

IQV appears in 25 ETFs tracked by SecuritiesDB, while ABBV appears in 40 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, IQV or ABBV?

Our quantitative analysis compares IQV and ABBV across nine fundamental dimensions. ABBV wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are IQV and ABBV correlated?

The 252-day correlation between IQV and ABBV is 0.180. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.